Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 266887Generated: October 30, 2026

9-Borabicyclo(3.3.1)nonane → 1'-(t-butyloxycarbonyl)-3,4-dihydro-3-oxospiro[1H-indene-1,4'-piperidine]

https://huagongshe.com/reaction/266887

Reaction equation

Participants

RoleNameHCIDCharge
Reactant9-Borabicyclo(3.3.1)nonaneHCID 78966—
ReactantTert-butyl Spiro[indene-1,4'-piperidine]-1'-carboxylateHCID 3653579—
ReactantHCID 178418287HCID 178418287—
SolventDiethyl EtherHCID 3283—
SolventTetrahydrofuranHCID 8028—
Product1'-(t-butyloxycarbonyl)-3,4-dihydro-3-oxospiro[1H-indene-1,4'-piperidine]HCID 1903043947%

Reaction Conditions

Temperature70 °C

Reaction Steps

To a solution of 661 mg (2.31 mmol) of 1'-(t-butyloxycarbonyl)spiro[1H-indene-1,4'-piperidine] [prepared by the method of Chambers, et al, J. Med. Chem., 1992, 35, 2036] in 5.0 ml of THF was added 5.8 ml (1.0M THF, 2.9 mmol) of 9-BBN. The reaction mixture was heated at 70° C. until TLC analysis indicated that the starting material was consumed. The solution was concentrated and the residue was dissolved in dichloromethane. The solution was cooled to 0° C. and 4.1 g (19.2 mmol) of PCC was added slowly over 15 minutes. The reaction mixture was warmed to room temperature and then to reflux for 30 minutes. The solution was then diluted with ether and filtered through a pad of a mixture of celite and florisil. Purification by flash chromotography (silica gel, hexane/ethyl acetate, 4:1) gave 326 mg (47%) of the title compound.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05652235
Source datasetuspto-grants-1997_07
ORD IDord-261222eb6d5f4122b23c831fe8a56690
Source noteuspto-grants-1997_07